Please assess the completion status of the following clinical trial:

Trial Title: Diabetes Assistant (DiAs) Control-to-Range (CTR) Nocturnal Closed-Loop Camp Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Clinical diagnosis of type 1 diabetes and using daily insulin therapy for at least one year and a Medtronic, Animas or Tandem insulin infusion pump for at least 3 months~2. The diagnosis of type 1 diabetes is based on the investigator's judgment; C peptide levels and antibody determinations are not required.~3. Age 10.0 - 35 years~4. Willingness to use a Sure-T or Contact Detach infusion set while at camp~Exclusion Criteria:~1. Diabetic ketoacidosis in the past month~2. Hypoglycemic seizure or loss of consciousness in the past 3 months~3. History of seizure disorder (except for hypoglycemic seizure)~4. Using an OmniPod insulin infusion pump~5. History of any heart disease including coronary artery disease, heart failure, or arrhythmias~6. Cystic fibrosis~7. Current use of oral/inhaled glucocorticoids, beta-blockers or other medications, which in the judgment of the investigator would be a contraindication to participation in the study.~8. History of ongoing renal disease (other than microalbuminuria).~9. Insulin pump users who supplement with injected intermediate or long acting insulin.~10. Subjects who take other anti-diabetic medications other than insulin..~11. Medical or psychiatric condition that in the judgment of the investigator might interfere with the completion of the protocol such as:~12. Inpatient psychiatric treatment in the past 6 months~13. Uncontrolled adrenal disorder~14. Abuse of alcohol~15. Pregnancy (verbal denial of pregnancy obtained with telephone informed consent, pregnancy test performed at camp before study devices are assigned).~16. Sexually active females who do not practice acceptable contraceptive methods to prevent pregnancy.

- Gender: ALL
- Minimum Age: 10 Years
- Maximum Age: 35 Years
- Healthy Volunteers: f

Study Arms:
- Closed-Loop Control with DiAs System (Type: EXPERIMENTAL): Subjects will use the Diabetes Assistant (DiAs) and will wear a Tandem t:slim insulin pump and a Dexcom G4 Platinum sensor with active low and high sensor glucose alarms. Subjects will be remotely monitored throughout the night in real time.
- Control Group, Sensor-Augmented Pump Therapy (Type: PLACEBO_COMPARATOR): Subjects will wear a Tandem t:slim insulin pump and a Dexcom G4 Platinum sensor with active low and high sensor glucose alarms. They will not use the Diabetes Assistant (DiAs) nor have remote monitoring.

Based on this trial design, predict the completion outcome and termination type (if applicable).